This study illustrated that temozolomide suppressed cell proliferation, migration, invasion, and angiogenesis, but accelerated cell apoptosis, autophagy in glioblastoma, as well as restricted tumor growth in vivo, by disrupting the LINC00470/EGR2/SOX4 axis. Here, SOX4 is linked to glioblastoma.